Aronow Wilbert S
Cardiology Division, New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, USA.
Future Cardiol. 2010 Nov;6(6):859-70. doi: 10.2217/fca.10.99.
The implantable cardioverter-defibrillator (ICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation not due to reversible causes. The American College of Cardiology/American Heart Association class I and IIa indications for an ICD are discussed. Patients with ICDs who need pacing should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing, at a rate of 70/min. Patients with ICDs should be treated with β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
植入式心脏复律除颤器(ICD)是治疗非可逆性病因所致危及生命的室性心动过速或心室颤动患者的最有效方法。本文讨论了美国心脏病学会/美国心脏协会关于ICD的I类和IIa类适应证。需要起搏治疗的ICD患者应接受双心室起搏,而非双腔频率适应性起搏,起搏频率为70次/分钟。ICD患者应接受β受体阻滞剂、他汀类药物以及血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗。